CAMBRIDGE, Mass., Dec. 30, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy-focused technology company, today announced a…
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
CAMBRIDGE, Mass., Dec. 19, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that Josh Swihart, Chief Executive Officer…
Industry's highest-capacity discrete analyzer delivers true walk-away automation for commercial laboratoriesWESTBOROUGH, Mass., Dec. 16, 2025 /PRNewswire/ -- Commercial laboratories face…
BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted…
CAMBRIDGE, Mass., Dec. 9, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that industry pioneer Zooko Wilcox, the founder…
December 10, 2025 16:06 ET | Source: AMSC Transaction Expected to be Accretive to Revenue and Earnings Expands Product Offerings…
December 09, 2025 21:50 ET | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) --…
December 09, 2025 21:42 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.…
SpectraStar™ XT Series Users Now Have Easier Access to KPM's Extensive Calibration Library for Confident Quality AssuranceWESTBOROUGH, Mass., Dec. 4,…